Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

: Glucagon Hydrochloride Solution (Active Comparator) - JSON Representation

Raw json | Download

{
  "resourceType" : "Group",
  "id" : "370702",
  "meta" : {
    "versionId" : "2",
    "lastUpdated" : "2025-05-28T13:34:35.405Z",
    "profile" : [
      🔗 "http://hl7.org/fhir/uv/ebm/StructureDefinition/conceptual-comparator-definition"
    ]
  },
  "text" : {
    "status" : "empty",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/cite-as",
      "valueMarkdown" : "Glucagon Hydrochloride Solution (Active Comparator) [Database Entry: FHIR Group Resource]. Contributors: Brian S. Alper, MD, MSPH [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 370702. Revised 2025-05-28. Available at: https://fevir.net/resources/Group/370702. Computable resource at: https://fevir.net/resources/Group/370702#json."
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/artifact-author",
      "valueContactDetail" : {
        "name" : "Brian S. Alper, MD, MSPH"
      }
    }
  ],
  "url" : "https://fevir.net/resources/Group/370702",
  "identifier" : [
    {
      "type" : {
        "coding" : [
          {
            "system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
            "code" : "ACSN",
            "display" : "Accession ID"
          }
        ],
        "text" : "FEvIR Object Identifier"
      },
      "system" : "urn:ietf:rfc:3986",
      "value" : "https://fevir.net/FOI/370702",
      "assigner" : {
        "display" : "Computable Publishing LLC"
      }
    }
  ],
  "title" : "Glucagon Hydrochloride Solution (Active Comparator)",
  "status" : "active",
  "publisher" : "Computable Publishing LLC",
  "contact" : [
    {
      "telecom" : [
        {
          "system" : "email",
          "value" : "support@computablepublishing.com"
        }
      ]
    }
  ],
  "description" : "Example of ConceptualExposureDefinition combining M11 IGBJ Protocol Example Eligibility Criteria PLUS exposure to Glucagon Hydrochloride Solution",
  "copyright" : "https://creativecommons.org/licenses/by-nc-sa/4.0/",
  "type" : "person",
  "membership" : "conceptual",
  "combinationMethod" : "all-of",
  "characteristic" : [
    {
      "code" : {
        "text" : "Member of"
      },
      "valueReference" : {
        🔗 "reference" : "Group/267506",
        "type" : "Group",
        "display" : "M11 IGBJ Protocol Example Eligibility Criteria"
      },
      "exclude" : false,
      "description" : "Member of M11 IGBJ Protocol Example Eligibility Criteria"
    },
    {
      "code" : {
        "text" : "assigned to"
      },
      "valueCodeableConcept" : {
        "text" : "Glucagon Hydrochloride Solution (Active Comparator) A single dose of 1 mg glucagon hydrochloride solution was administered intramuscular (IM)"
      },
      "exclude" : false,
      "description" : "assigned to Glucagon Hydrochloride Solution"
    }
  ]
}